Get In Touch

Structural Heart Devices Market Promises a Robust 7.5% CAGR Growth, Thanks to Rising Non-invasive Procedures

Rising cases of structural heart disease are likely drive robust 7.5% CAGR in the structural heart diseases market to reach $13 bn in 2027. Rising heart diseases and growing research in structural heart diseases are expected to drive growth of the structural heart devices market.

Among the available devices in the market, the Tissue Engineered Heart Valves are expected to drive new applications in the market. These valves also known as biological valves offer new ways of replacement surgeries, which are organic and less-invasive as opposed to conventional valves. Moreover, these also offer new opportunities due to advent of personalized medicine. This segment is likely to reach US$8 bn in 2027.


The structural heart devices market is expected to expand significantly in Asia Pacific region. The market promises robust opportunity in North America as large population of patients with heart disease, spread of obesity, and growing innovation will drive growth. In Asia Pacific, the rising disposable income, growing access to healthcare, and rising obesity in urban areas are expected to drive the fastest growth in the region.

Rising Heart Failure Cases to Drive New Opportunities for Growth and Innovation

The structural heart device is widely used in various cardiac procedures for acquired diseases as well as congenital diseases. These include septal defects, valvular diseases, venous obstructions, arterial diseases, and issues like atrial appendage. Among these, rising heart failure cases promise the largest application in the structural heart devices market. According to Center for Disease Control and Prevention, there are over 5.7 million cases of heart failure in the United States. Additionally, these amounts to 1 in 10 death cases are attributed to heart failures. CDC estimates that each year, the disease costs over $30 billion to United States government each year. Moreover, current patients with heart failure possibilities will likely face fatal consequences without the heart replacement surgeries within a 5 year period. This fatal nature, and importance of structural heart devices in treating the fatal disease is likely to create new opportunities for players in the market.

Hybrid Procedures Remain Most Promising to Drive Growth

Surgical and interventional procedures are likely to remain major applications in the structural heart devices market. Moreover, the evolution of hybrid procedures promises a robust application in the area. These include modern equipment, ventilation, and facilitation of both the procedures are important factors for end-consumers. Their cost-effective application, high imaging systematic application, and ventilation procedures will drive growth. The advancements in Computed Tomography or CT scans are also expected to create new opportunities for growth in the structural heart devices market. These are likely important for growth of catheter technologies.

Global Structural Heart Devices Market: Segmentation

Structural Heart Devices Market by Product

  • Biological/Tissue Valves
    • Transcatheter Heart Valves
    • Surgical Heart Valves
  • Mechanical Heart Valves
  • Annuloplasty Rings
  • Occluders
  • Accessories

Structural Heart Devices Market by Procedure

  • Replacement Procedures
  • Repair Procedures

Structural Heart Devices Market by Indication

  • Valve Stenosis
  • Valve Regurgitation
  • Cardio Myopathy
  • Congenital Heart Defects
  • Others

Structural Heart Devices Market by Region

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • France
    • U.K.
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports thrive to provide clients to serve their overall research requirement.


Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]

7 of 10 large enterprizes view our ToC to take the right decision.

View Report ToC